Monday, 21 August 2017

Protecting Your Process From Mycoplasma...

Protecting Your Process From Mycoplasma Contamination

Protecting Your Process From Mycoplasma...

Posted by Bioprocess Pharmaceutical Filtration Team on Wednesday, August 16, 2017 Plant shutdown, a shortage of key products, patients unable to access important drugs, profits hit … the consequences of a biological contamination can be devastating for a biopharmaceutical manufacturer. Detection of a viral contamination at a manufacturing facility can halt production of drugs with significant sales loss, potential lawsuits and even decline in stock value as a result.​ Preventing...Read More


#IWork4Parker
Parker Advocates
Post a Comment